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Abstract 
Homeostasis of the central nervous system (CNS) microenvironment is maintained by 
the blood-brain barrier (BBB) which regulates the transport of molecules from blood 
into brain and backwards. Many disorders change the functionality and integrity of the 
BBB. Glucocorticoids are being used sucessfully in the treatment of some disorders 
while their effects on others are questionnable. In addition, conflicting results between 
clinical and experimental experience using animal models arose, so that the results of 
molecular studies in animal models need to be revisited in an appropriate in vitro model 
of the human BBB for more effective treatment strategies. Using the human brain 
microvascular endothelial cell line hCMEC/D3, the influence of glucocorticoids on the 
expression of barrier constituting adherens junction and tight junction transmembrane 
proteins (VE-cadherin, occludin, claudins) was investigated and compared to other 
established BBB models. In hCMEC/D3 cells the administration of glucocorticoids 
induced expression of the targets occludin 2.75+0.04-fold and claudin-5 up to 2.32+ 
0.11-fold, which is likely to contribute to the more than threefold enhancement of 
transendothelial electrical resistance reflecting barrier tightness. Our analyses further 
provide direct evidence that the GC hydrocortisone prevents endothelial barrier 
breakdown in response to pro-inflammatory stimuli (TNFα administration), which 
could be demonstrated to be partly based on maintainance of occludin levels. Our 
studies strongly suggest stabilisation of BBB function as a mode of GC action on a 
molecular level in the human brain vasculature. 
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Introduction  
Homeostasis of the central nervous system (CNS) microenvironment is essential for 
its normal function and is maintained by the blood-brain barrier (BBB) (Pardridge, 
1988; Risau & Wolburg, 1990). The cell types composing the BBB are endothelial 
cells, pericytes and the end-feet of astrocytes. Among them, several recent studies 
have highlighted the importance of the brain endothelial cells to form the 
morphological correlative of the BBB in this modular organization: the permeability 
properties of the BBB reflect, to a major degree, the tightness of the intercellular 
junctions between brain microvascular endothelial cells (Rubin et al., 1991). Tight 
junctions (TJ) seal the endothelial cell layer and are especially well developed in 
endothelia of the BBB, in contrast to blood vessels outside the CNS, the TJs of which 
are less elaborate and facilitate exchange of solutes and macromolecules and allow 
leukocyte trafficking (Simionescu & Simionescu, 1991). Two different classes of 
integral membrane proteins constitute the TJ strands, occludin and members of the 
claudin protein family (D'Atri & Citi, 2002). The claudins, which have been identified 
in brain microvascular endothelial cells include claudin-5, claudin-12 (Matter & 
Balda, 2003), claudin-1 (Liebner et al., 2000)  and claudin-3 (Wolburg et al., 2003; 
Coisne et al., 2005). Moreover, numerous studies have demonstrated conclusively 
that TJ formation depends very much on the VE-cadherin-based adherens junctions 
(Lampugnani et al., 1995; Gumbiner, 1996).  
Disruption of the blood-brain barrier (BBB) has been described as a crucial step of 
neuroinflammatory conditions including brain tumors, cerebral ischemia, meningitis, 
encephalitis, and multiple sclerosis (MS). Therapeutic strategies for several of these 
diseases include treatment with GC (Engelhardt, 2000; Qizilbash et al., 2002) but a 
detailed understanding of their mechanism of action is still outstanding. GCs exert a 
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variety of beneficial effects under neuroinflammatory conditions by acting on immune 
cells, the microglia and the blood-brain barrier, but they do fail to improve cerebral 
edema following stroke or even show adverse effects like the induction of 
hypertension in chronical administration, so that there is a clear need to further 
elucidate their molecular mode of actions  (Reichardt et al., 2006). Effects of GCs like 
hydrocortisone (HC) are known to be mediated by the glucocorticoid receptor (GR) 
(Beato, 1989). GR can bind to specific DNA sequences (glucocorticoid-responsive 
element, GRE) in the 5’-flanking region of target genes and transactivate gene 
transcription (Beato, 1989). Despite great progress in the field, many questions 
concerning the mechanism of GCs remain unanswered, for example the contribution 
of genomic and non-genomic effects or the cell-type specificity of their action.  
Barrier-tightening effects of GC treatment has been demonstrated for cerebral 
endothelial cells in vitro (Hoheisel et al., 1998; Romero et al., 2003; Förster et al., 
2005; Weksler et al., 2005). Matching data supporting an important role for GC-
mediated tightening of the BBB by junctional protein induction have been 
demonstrated in vivo in the mouse (Förster et al., 2006). GCs have further been 
shown to effectively restore barrier in a rat model of MS (Paul & Bolton, 1995; 
Schmidt et al., 2003). Moreover, using serial MRI recordings, a reduction in the 
number of enhancing lesions has been observed in patients suffering from optic 
neuritis and MS after high-dose GC treatment and in clinical studies (Grauer et al., 
2001).  
 
Based on these effects, researchers have begun to use diverse GCs for the in vitro-
differentiation of in vitro models of the BBB (Hoheisel et al., 1998; Romero et al., 
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2003; Förster et al., 2005; Weksler et al., 2005). In vitro BBB models are isolated 
endothelial cell culture systems from brain capillaries that allow for the study of BBB 
functionality, e.g. GC action, separated from feedback or indirect systems that operate 
in vivo. Several in vitro BBB systems have been developed and various procedures 
have been applied to isolate and culture brain microvascular endothelial cells. They 
differ with respect to e.g. isolation procedure, culture conditions, cell type and origin 
(tissue and species) and culture system. Such a diversity leads to in vitro BBB 
systems with different characteristics, which makes the comparison and transference 
of results between these systems problematic.  
For the transference of results to therapy, it is a necessary step to characterize human 
brain endothelial cell features in response to GCs versus those from animal origin and 
to delineate the molecular targets of GC action also in the human system. There was 
no established immortalized human brain endothelial cell line so far that could be 
used as an adequate in vitro-model to investigate the effects of GCs on the 
differentiation and regulation of the blood brain barrier in humans. Due to this 
shortcoming, a transference of molecular mechanisms induced by GC administration 
in animal models to the human system has not yet been achieved. After establishing 
hCMEC/D3 as an immortalized validated human model of the blood brain barrier 
(Weksler et al., 2005; Cucullo et al., 2007) we can now focus onto analysing 
molecular mechanisms of GC action at the human blood brain barrier. In the present 
study, the in vitro expression of the GR and the cellular response to the pro-
inflammatory cytokine TNFα and the GC HC was examined in hCMEC/D3 cells. 
Data are then compared to established GC-responsive brain endothelial cell lines from 
murine, rat or porcine origin characterised previously, and qualitative and quantitative 
differences are discussed. The future use of the cell culture model hCMEC/D3 might 
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help to understand and hopefully even treat neurological disease in a more effective 
way. 
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Methods 
 
Chemicals. Hydrocortisone was purchased from Sigma, Taufkirchen, Germany. 
Collagen IV was purchased from Fluka, Taufkirchen, Germany. 
 
Isolation and culture of cerebral endothelial cells. The immortalised human brain 
microvascular endothelial cell line hCMEC was generated as described (Weksler et 
al., 2005). The human brain microvessel endothelial cell line hCMEC/D3 retains the 
morphological characteristics of primary brain endothelial cells and expresses specific 
brain endothelial markers and cell surface adhesion molecules (Weksler et al., 2005). 
Moreover, it was recently demonstrated that, when cultured under flow conditions, 
these cells maintain in vitro the physiological permeability barrier properties of the 
BBB in situ even in the absence of abluminal astrocytes (Cucullo et al., 2007):  
hCMEC/D3 cells do retain the expression of endothelial and BBB markers (Weksler 
et al., 2005), hCMEC/D3 cells retain an aerobic metabolic pathway and exhibit an 
inflammatory response, i.e. barrier failure, extravasation of leukocytes of these cells 
(Cucullo et al., 2007). 
 
Cell Cultures. hCMEC/D3 were cultivated as described by Weksler et al (Weksler et 
al., 2005) with modifications: until confluence, cells were grown on collagen IV-
coated flasks in EGM-2 medium from Clonetics (Cambrex BioScience, Workingham, 
UK) consisting of EBM-2 basal medium amended with 2.5 % FCS and the growth 
factors VEGF, IGF-1, EGF, basic FGF, heparin as well as ascorbate and gentamycin 
from the EGM-2 BulletKit according to the manufacturers recommendation as 
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previously described (Weksler et al., 2005). Briefly, for EGM-2 preparation, 500 µl 
bFBF single aliquots and 125 µl of each, IGF1, ascorbic acid, VEGF, EGF, Heparin 
single aliquots were added to 500 ml EBM-2 basal medium as described in the 
manufacturers recommendation. As important modification to this protocol, no HC 
supplementation from the EGM-2 bullet kit was added to the growth medium. After 
reaching confluence, the medium was changed to a serum-reduced but hormone-
supplemented cell differentiation medium:  consisting of EBM-2 basal medium 
containing  0.25 % FCS and 100 nM HC, but  without  other added growth factors 
described for the growth medium. 
All cultures were supplemented with 100 IU/ml penicillin and 100 mg/ml 
streptomycin (1% PEST). Cells were maintained in an atmosphere of 5.0% CO2 / 95 
% air and at 37 °C. 
 
Electrophoresis and immunoblotting.  
Cells were plated at a density of 2.5*104 cells/cm2 in collagen IV-coated (Fluka, 
Taufkirchen, Germany) petri dishes and grown to confluence. At confluence, cells 
were maintained in FCS-reduced differentiation medium (see above) and treated with 
TNFα and HCs as indicated in the figure legends.  
For western blot analyses, cells were then dissolved in Laemmli sample buffer 
(Laemmli, 1970) and subjected to sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE, 15 % gels).  
Protein contents were quantified by protein estimation directly from SDS-PAGE 
loading buffer using 0.1 % (w/v) Amidoschwarz (AppliChem, Darmstadt, Germany) 
in 25 % (v/v) Methanol/ 5 % (v/v) acetic acid. For immunoblotting, proteins were 
transferred in Kyhse-Andersen transfer buffer (Kyhse-Andersen, 1984) to Hybond 
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nitrocellulose membranes (Amersham, Braunschweig, Germany) which were blocked 
with 10 % (w/v) low fat milk in phosphate buffered saline (PBS, pH 7.4) and 
incubated overnight at 4 °C with the respective primary antibody (in PBS plus 10 % 
low fat milk). The polyclonal rabbit antibodies against occludin, claudin-5 and 
claudin-1 were were purchased from Zymed Laboratories, California, USA. The 
polyclonal rabbit antibody sc-8992 against hGR was purchased from Santa Cruz 
Biotechnologies, California, USA. The polyclonal rabbit antibodies against occludin, 
claudin-5, hGR and VE-cadherin were used at a dilution of 1:1000. As secondary 
antibody, horseradish peroxidase-labelled goat anti-rabbit IgG (Jackson Immuno Res. 
Lab., West Grove, PA, USA) was used diluted 1:3000 with PBS. The polyclonal goat 
antibody sc-6458 against VE-cadherin was purchased from Santa Cruz 
Biotechnologies, California, USA. As secondary antibody, horseradish peroxidase-
labelled donkey anti-goat IgG (Jackson Immuno Res. Lab., West Grove, PA, USA) 
was used diluted 1:3000 with PBS.  Bound immunoglobulins were visualised by the 
enhanced chemiluminescence technique (ECL, Amersham). Densitometric analysis 
using Scion Image Beta 4.02 (Scion Corp., MD, USA) was performed for 
quantitation.  
 
Quantitative real-time RT-PCR 
For real-time RT-PCR, cDNA was synthesized using iSCRIPT cDNA synthesis kit 
(BioRad) and 1 µg of RNA from hCMEC/D3 cells treated or untreated with TNFα 
and HC. Human occludin, claudin-1, claudin-3, claudin-5, VE-cadherin, and GAPDH 
primers were designed using the Primer Express Software (Applied Biosystems) and 
obtained from MWG Biotech. Real-time RT-PCR was performed using the 
SYBR®Green PCR Master Mix (Applied Biosystems). Primers occludin forward (5’- 
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TCC ATT GGC AAA GTG AAT GA-3’), occludin reverse (5’ AGA GGT GCT CTT 
TTT GAA GG-3’), GAPDH forward (5’- GAG TCA ACG GAT TTG GTC GT-3’), 
GAPDH reverse (5’- GAT CTC GCT CCT GGA AGA TG-3’), claudin-1 forward (5’- 
CCG TTG GCA TGA AGT GTA TG-3’), claudin-1 reverse (5’- AAG GCA GAG 
AGA AGC AGC AG-3’), claudin-3 forward (5’- AAG GTG TAC GAC TCG CTG 
CT-3’), claudin-3 reverse (5’- AGT CCC GGA TAA TGG TGT TG-3’), claudin-5 
forward (5’- GAG GCG TGC TCT ACC TGT TT-3’), claudin-5 reverse (5’- GCC 
AGG TAT GAG ATC GTG GT-3’), VE-cadherin forward (5’- GCC AGG TAT GAG 
ATC GTG GT-3’), VE-cadherin reverse (5’- GTG TCT TCA GGC ACG ACA AA-
3’). The ABI PRISM 7300 SDS software (Relative quantification study) was used to 
determine the cycle threshold (Ct) for each reaction and gene expression was 
normalized to expression of the endogenous housekeeping gene, glyceraldehyde 
phosphate dehydrogenase (GAPDH) based on the the 2^[ -delta delta Ct ] method (where 
Ct means threshold cycle).  
 
Bioelectric and permeability assessments. Cells were plated on top of collagen IV-
coated transwell chambers for 6-well plates (24 mm diameter, membrane material: 
polyethylene terephthalate (PET), 0.4 µm pores, pore density/cm2 1.6 x 106) (Falcon, 
Heidelberg, Germany) at densities of 2.5 x 104/ cm2 cells per well. When they had 
reached confluence at day 5, the different experimental sets of cells were transferred 
to differentiation medium containing reduced amounts of FCS (see above) and treated 
with TNFα or HC as indicated.  
Resistance measurement: 
Transendothelial electrical resistance (TER) was measured using an assembly 
containing current-passing and voltage-measuring electrodes (volt ohm meter EVOM, 
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equipped with a STX2 "chopstick" electrode set, World-Precision Instruments Inc., 
New Haven, CT, USA). Resistances of blank filters were subtracted from those of 
filters with cells before final resistances (in Ω*cm2) were calculated. All experiments 
were repeated at least 6 times. 
FITC-dextran and fluorescein flux measurement: Confluent monolayers treated or 
untreated with HC (see figure legends) were washed in prewarmed HEPES buffer (10 
mM HEPES, pH 7.2, 0,1 % BSA, 4.5 % glucose) and subsequently preincubated for 5 
min in HEPES buffer at 37 °C. FITC-dextrans (Sigma) were purified from 
unconjugated FITC by size exclusion chromatography (Biogel P2 Polyacryamide gel, 
BioRad, München, Germany). Paracellular flux measurement was started by adding to 
the upper chamber of the Transwell system 100 µl of 50 mg/ml of 4, 10, 70 or 150 
kDa FITC-dextran or 100 µl of 5 mg/ml fluorescein, respectively, in HEPES buffer to 
a final concentration of 1 mg/ml FITC-dextrans or 0.1 mg/ ml fluorescein, to the 
upper chamber. Paracellular flux was assessed by taking 100 µl aliquots from the 
outer chamber every 15 min during the first 90 min of incubation. (FITC-dextran and 
fluorescein fluxes had initially been monitored over a duration of 360 min, however, 
at incubation times longer than 90 min, cytotoxic effects of the labeled compounds on 
hCMEC/D3 cells were occasionally observed by brightfield microscopy in 
preliminary experiments). Fluorescence was measured using a Wallac Victor2 
fluorescence spectrophotometer (Perkin-Elmer, Überlingen, Germany) with excitation 
and emission at 485 nm and 535 nm, respectively. The fluorescein and FITC-dextran 
clearance through the monolayer was compared to control clearance of uncoated wells 
and the volume cleared was plotted against time and the slopes of the curves were 
fitted using linear least square regression to calculate the permeability coefficients 
(Pe) of the endothelial monolayer according to the method of van Bree (van Bree et 
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al., 1988) . Blank filters coated with collagen IV were shown to not significantly 
restrict the permeation of the larger dextranes. 
 
 
Analysis and Statistics. Values for TER and gene expression were averaged to 
establish a single value for hCMEC/D3 cells under different experimental conditions. 
Throughout, averaged values were reported as means + standard error (SE). The 
indicated statistical test (Mann-Whitney U-test) was performed assuming significance 
for P < 0.05  (*), high statistical significance at p < 0.001 (**).
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Results 
 
HC responsivity of hCMEC/D3 cells 
In an effort to investigate HC-sensitivity of hCMEC/D3 cells we examined GC 
receptor (GR) expression in this cell line by RT-PCR analysis, Western blot and 
immunocytochemistry (Fig. 1). RT-PCR analysis showed a dose-dependent 
downregulation of GR transcript to 0.81 + 0.06-fold after after 48 hours of treatment 
with 50 nM HC, and to 0.63 + 0.1-fold after 48 hours of treatment with 100 nM HC, 
respectively, in hCMEC/D3 cells (n=6) (Fig. 1A). In cell lysates from untreated 
hCMEC/D3 cells, there was a strong signal for GR protein detectable by Western blot 
analysis (Fig. 1B). HC supplementation for 48 hours at physiological concentration 
(100 nM) led to a ligand-dependent reduction in detectable GR protein to 83 + 0.6 % 
of untreated cells as evaluated by densitometric analysis of Western blots (n = 3) (Fig. 
1B). HC treatment further stimulated GR translocation from the cytosol to the nucleus 
as evaluated by immunocytochemistry of treated and untreated hCMEC/D3-cells (Fig. 
1C): in untreated hCMEC/D3 cells, GR protein (green) was weakly detected as 
cytoplasmic staining (Fig 1C). Upon HC treatment, nuclear concentration of GR 
(green) was confirmed, visualised by propidium iodide nuclear counterstaining (red) 
(Fig. 1C): after HC treatment, fluorescence was concentrated in the nucleus in 
hCMEC/D3 cells as confirmed by the use of computer imaging software (Adobe 
Photoshop CS, Seattle, WA, USA) to merge the individual images for FITC-GR and 
propidium iodide counterstain to assess similarity of staining pattern. 
Summarising protein expression data collected by western blot analysis and 
immunocytochemistry, we show that ligand-bound GR is translocated to the nucleus 
Carola Förster, Hydrocortisone induction of BBB properties in human adult brain endothelial cell 
 
15
15
in human BBB endothelial cells hCMEC/D3 as reported for classical GC-responsive 
cells (Beato & Klug, 2000). 
 
 
Effects of HC on brain EC resistance and permeabililty 
We were able to develop a serum-reduced but hormone-supplemented cell 
differentiation medium based on the media previously described for murine cEND 
brain microvascular endothelial cells (Förster et al., 2005) and hCMEC/D3 cells 
(Weksler et al., 2005): until confluence, cells were grown in EGM-2 medium from 
Clonetics (Cambrex BioScience, Workingham, UK) in the presence of 2.5 % FCS and 
the growth factors VEGF, IGF-1, EGF, basic FGF, heparin as well as ascorbate and 
gentamycin from the EGM-2 BulletKit as previously described (Weksler et al., 2005) 
but without HC supplementation used in this reference. The amounts of growth factor 
single aliquots used for this study are detailed in the method section. After reaching 
confluency, the medium was changed to the following serum-reduced but hormone-
supplemented cell differentiation medium: medium contained 0.25 % FCS and 100 
nM HC, but was lacking other added growth factors. 
HC supplementation of the serum-reduced cell differentiation medium led to a 
significant increase in TER across the hCMEC/D3 monolayer. TER in the absence of 
HC was 69 + 19.3 Ω x cm2 while HC administration caused a significant increase of 
TER to the range of 199 + 5 Ω x cm2 (Fig. 2A).  
 
To further validate the hCMEC/D3 BBB model, the paracellular permeability of 
macromolecules like non-charged  FITC-dextrans of molecular masses 4 kDa, 10 
kDa, 70 kDa, and 150 kDa and of fluorescein (Mr = 300 Da) was tested by assessing 
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flux across the hCMEC/D3 monolayer after removal of unconjugated FITC from the 
uptake mix by size exclusion chromatography as previously described (Romero et al., 
2003; Förster et al., 2005) (Table 1). For this, we determined the permeability 
coefficients using the slopes of the curves representing cleared volume versus time 
according to van Bree (van Bree et al., 1988). The permeability of small 
macromolecules across the monolayer of hCMEC/D3 cells in differentiation medium 
(0.25 % FCS) supplemented with 100 nM HC was significantly decreased over 90 
min for fluorescein (by 48 + 6 %) and the for the smallest FITC-dextran (4-kDa) (by 
37 + 4%) comparative to control cells maintained in HC-free medium containing 0.25 
% FCS (n = 6-8 filters, 3 independent assays). No significant decrease versus 
untreated cells was observed for the FITC-dextrans 10-kDa, 70-kDa and 150-kDa 
(Table 1). According to the classical pore theory (van Bree et al., 1988), one can 
relate the molecullar radius of the solutes assessed (R) with their free diffusion 
coefficients (D) and the permeability coefficient Pe (Table 1). The calculation of the 
apparent pore size of the paracellular pathway revealed the existence of cylindrical 
pores of two apparent sizes, a large pore population with a radius of 92 + 9 Å and a 
small pore population with a radius of 12.47 + 0.45 Å within the hCMEC/D3 
monolayer. Hydrocortisone treatment reduced the apparent pore size of the small 
pores to a radius of 7.9 + 0.3 Å consistent with the reduced permeability of the 
monolayers following HC treatment. The calculation of the fractional porous area/ 
path length as through the cell monolayer, i.e. Ap/dx, was calculated as a measure of 
steric hindrance through the pores in the D3 monolayer (Table 1). Results show that 
steric hindrance appears to be significantly reduced by hydrocortisone treatment for 
all the molecules tested as compared to untreated cells.  
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The presented data underline that HC-induced enhanced resistance to electrical 
current appears to be mainly caused by closure of small-sized pores, responsible for 
the passage of fluorescein and the smallest of the dextrans tested (4 kDa), but that 
other effects independent of the tight junction molecules seem to be additionally 
induced by HC treatment. Taken together, bioelectric and paracellular flux 
measurements demonstrate that these cells are an appropriate HC-responsive model to 
test HC effects on the human BBB. 
 
Junctional protein expression in response to HC treatment in hCMEC/D3 cells 
TJ and adherens junction proteins are known to be key mediators of blood brain 
barrier sealing and maintenance. In order to identify potential mechanisms of HC 
preservation of the blood brain barrier we therefore assessed changes in junctional 
protein levels (Fig. 3) and gene expression (Tab. 1). A positive effect of HC on barrier 
molecule expression of the cells could be verified for occludin and claudin-5. 
Claudin-5 contents were increased by 62 + 22 % as compared to the untreated control, 
as assessed by western blot analysis and and densitometric quantitation. Occludin 
contents were increased by 16 + 7 % as compared to the untreated control. No effects 
were detected in the case of claudin-1 and VE-cadherin (Fig. 3). 
 
Also by real time-RT-PCR analysis we could show that treatment with HC influenced 
gene expression of junctional protein encoding genes differently in a concentration-
dependent manner (Table 2). As described previously for murine brain microvascular 
endothelial cells (Förster et al., 2005; Förster et al., 2006), treatment with HC induced 
occludin gene expression: control and HC-treated endothelial cells studied expressed 
occludin, occludin levels were however significantly increased in response to HC 
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treatment, with the effect being most pronounced at concentrations between 50 – 100 
nM HC.  
The claudins -1, -3, and -5 showed different responses to the HC treatment regimens: 
while claudin-5 gene expression showed a strong induction in response to 100 and 
500 nM HC treatment, HC treatment did not lead to an increase in claudin-1 or 
claudin-3 levels as compared to untreated cells. For VE-cadherin, an upregulation of 
gene expression in response to HC was equally not observed, while treatment with the 
highest concentration (1000 nM) of HC even reduced gene expression in the case of 
claudin-1, claudin-3, claudin-5 and VE-cadherin, presumably due to cytotoxic effects 
of this supraphysiological concentration. The influence of HC on hCMEC/D3 cells 
was observed from 0.5 till 24 hours after the beginning of the treatment. We received 
most pronounced differences in gene expression after a duration of eight hours, a 
longer treatment did not lead to any differences.  
 
HC preservation of the endothelial barrier in response to TNFα treatment  
 
MS is a very common chronic neurological disease which is characterized by the 
infiltration of the central nervous system by T-cells reactive against myelin across a 
compromised BBB (Schwartz & Kipnis, 2005). The inflammatory mediator TNFα 
seems to play a key role within the pathological processes of MS and experimental 
autoimmune encephalomyelitis (EAE) as an animal model of MS (Weber & 
Rieckmann, 1995; Korner & Sedgwick, 1996; Pan et al., 1996). In order to identify 
functional changes in the brain endothelium, we assessed TER and barrier 
constituting junctional protein and mRNA levels in response to treatment with the 
pro-inflammatory cytokine TNFα and a combination of TNFα and HC treatment (Fig. 
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4, Table 3). In order to test whether HC treatment prevents a compromise of BBB 
function in response TNFα administration, we assessed TER of untreated monolayers 
kept in differentiation medium (0.25 % FCS) for 48 h, of monolayers treated for 48 h 
with HC in differentiation medium, and compared the values with monolayers kept in 
differentiation medium (0.25 % FCS) for 48 h and then additionally treated for 8h 
with TNFα or monolayers kept in HC-supplemented differentiation medium for 48 h 
and then additionally treated for 8h with TNFα  (Fig. 4A). We were able to show that 
8 hours TNFα treatment led to a reduction in TER from 74 + 12 Ω*cm2  in control 
cells, to 42 + 7 Ω*cm2 in TNFα−treated cells, while treatment with HC increased 
TER values to 324 + 33 Ω*cm2. Pretreatment with HC before TNFα administration 
effectively prevented barrier breakdown, TER values amounted to 157 + 27 
Ω*cm2(Fig. 4A). 
 
In order to identify potential mechanisms of HC preservation of the blood brain 
barrier under pro-inflammatory conditions we assessed changes in junctional protein 
levels and gene expression (Fig. 4B, Table 3). A significant reduction in levels of the 
TJ proteins occludin and claudin-5 was observed by Western Blot and densitometric 
quantitation (Fig. 4B,C) which could contribute to the negative effect of TNFα on 
barrier properties. 8 h of TNFα-treatment caused a decrease in occludin protein to 75 
+ 1 % of untreated cells. Pretreatment with HC before TNFα administration prevented 
occludin loss, we were able to detect 110 + 1.5 % of occludin protein levels as 
compared to untreated cells. When treated with HC alone, occludin contents were 
significantly increased to 139 + 4 % of control values. Comparably, 8 h of TNFα-
treatment caused a decrease in claudin-5 protein to 57 + 1 % as compared to the 
untreated control. Simultaneous administration of TNFα and HC did however not 
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prevent claudin-5 loss as effectively as in the case of occludin, we were still able to 
detect claudin-5 protein levels reduced to 79 + 2 % of untreated cells. When treated 
with HC alone, claudin-5 contents changed significantly as compared to untreated 
cells (increased to 110 + 1.5 % of control) (Fig. 4B). We also assessed whether the 
inflammatory cytokine or the HC would influence levels of the adherens junction 
protein VE-cadherin could however not detect significant changes under most 
treatments. Surprisingly, only HC treatment concomitant with TNFα-treatment led to 
an increase in detectable VE-cadherin protein (118 + 5 % of control) 8 h after 
treatment (Fig. 4B,C). 
 
Also by real time-RT-PCR analysis we could show that treatment with the 
inflammatory mediator TNFα alone or simultaneous treatment with HC influenced 
gene expression of junctional components differently (Table 3).  
All the endothelial cells studied expressed occludin. Occludin mRNA levels were not 
reduced in response to 8 hours TNFα treatment. Co-treatment with TNFα/ HC 
maintained occludin gene expression at the control level. As described previously 
(Förster et al., 2005; Förster et al., 2006), treatment with HC alone even stronger 
induced occludin gene expression. In contrast, the expression of claudin-5 and VE-
cadherin was affected discordantly by 8 hours of TNFα treatment. While claudin-5 
gene expression decreased in response to TNFα treatment, HC treatment led to a 
strong increase in claudin-5 levels as compared to untreated cells. Concommitant 
TNFα/ HC treatment prevented a downregulation of gene expression and the amounts 
of claudin-5 transcript did significantly  exceed the levels measured in control cells. 
The situation differed from observations in the case of VE-cadherin: a downregulation 
of gene expression in response to TNFα was equally observed and could be prevented 
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with simultaneous HC treatment while treatment with the GC HC alone did not 
significantly increase gene expression levels (Table 3).  
The influence of TNFα on hCMEC/D3 cells was observed from 0.5 till 24 hours after 
the beginning of the treatment. We observed most pronounced differences in gene 
expression after a period of eight hours, a longer treatment did not lead to any 
differences.  
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Discussion:  
Breakdown of the BBB is a key feature of neuroinflammatory conditions, such as MS, 
encephalitis, meningitis, brain tumors and cerebral ischemia (Hamann et al., 1995; 
Rosenberg, 2002; Sellner & Leib, 2006). Therapeutic strategies for such diseases with 
impaired BBB function include treatment with GCs (Engelhardt, 2000) although the 
mechanism of GC action is still not precisely determined. Barrier tightening effects of 
GC treatment have so far been demonstrated in clinical studies (Grauer et al., 2001), 
in vivo in animal models (Paul & Bolton, 1995; Schmidt et al., 2003; Förster et al., 
2006), and in isolated cerebral endothelial cells from murine (Förster et al., 2005) or 
rat (Romero et al., 2003) origin identifying molecular targets for GC action at the 
cellular level. The verification of identified molecular GC targets in human cells has 
however not yet been achieved although necessary in order to apply  results from 
diverse animal models to man and  to further prospective therapeutic exploitation. 
For the characterisation of hCMEC/D3 GC responsivity, we considered it appropriate 
to initially examine GR receptor status and barrier induction in this cell line. Our 
results indicated that human hCMEC/D3 cells express the GR. Our data further 
showed that GR message and protein in the presence of ligand is reduced in a 
concentration dependent manner. Remaining GR protein is translocated from the 
cytosol to the nucleus in hCMEC/D3 cells, as described for classical GC-responsive 
cells (Beato, 1989). Hormone-dependent down-regulation of steroid receptors, i.e. GR 
and the related progesterone receptor (PR), has been demonstrated in the past (Beato 
& Klug, 2000; Lange et al., 2000) and might be necessary for the attenuation of 
transcriptional responses in tissues continually exposed to ligand (Shen et al., 2001), a 
situation occuring precisely in the blood vessel-lining endothelial cells. 
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The GC HC was found to significantly induce barrier properties in the hCMEC/D3 
BBB model. The maximal effect of HC was reached at a concentration of 100 nM or 
above, which is well in the physiological concentration range of HC in mammalian 
blood between 70 - 550 nM (Karlson et al., 1994). GC treatment nearly tripled TER 
values across hCMEC/D3 monolayers up to 200 Ω*cm2. Treatment with HC further 
lowered the permeability of monolayers of hCMEC/D3 cells for fluorescein to 48 + 6 
% of untreated cells and for the smallest uncharged macromolecule (FITC-dextran 4 
kDa) to 37 + 4 % of untreated cells, while the permeability of higher molecular 
weight dextrans remained unaltered. The calculation of the apparent pore size of the 
paracellular pathway had revealed the existence of cylindrical pores of two apparent 
sizes, a large pore population with a radius of 92 + 9 Å and a small pore population 
with a radius of 12.47 + 0.45 Å within the hCMEC/D3 monolayer. Hydrocortisone 
treatment reduced the apparent pore size of the small pores to a radius of 7.9 + 0.3 Å 
consistent with the reduced permeability of the monolayers following HC treatment. 
Results further showed that steric hindrance as represented by the permeability to 
diffusion coefficient (P/D) appears to be significantly reduced by hydrocortisone 
treatment for all the molecules tested as compared to untreated cells. The values 
obtained for HC-treated cells hereby very closely match the data of van Bree who 
described the existence of longitudinal pores in brain endothelial cell monolayers 
from bovine origin (van Bree et al., 1988). As an explanation, one might have to 
consider potential effects of HC on the endothelial cell glycocalyx in addition to the 
tight junction itself. Interestingly, Chappel et al. only recently reported such effects of 
hydrocortisone on the endothelial glycocalyx, the diminution of which increases 
capillary permeability, suggesting that the glycocalyx contributes to endothelial 
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permeability barrier formation and is yet another target for hydrocortisone action 
(Chappell et al., 2007). Effects on the endothelial glycocalyx of D3 monolayers might 
thus have occured independently of effects on tight junction molecules. 
Future investigation will thus have to clarify the degree of pore size reduction and a 
possible reduction in pore number by HC treatment and have moreover to address so 
far unacknowledged effects on the endothelial glycocalyx. 
Comparable effects on barrier tightness have been previously reported under HC 
treatment for the murine brain microvascular endothelial cell line cEND (Förster et 
al., 2005; Förster et al., 2006), primary porcine BCECs (Hoheisel et al., 1998), rat 
brain microvascular endothelial cells (Romero et al., 2003) and for cells of epithelial 
origin (Nguyen & Neville, 1998; Woo et al., 2000). The data are further  concordant 
with clinical reports describing the barrier closing effects of GCs on MRI gadolinium 
enhancement in acute demyelinating lesions (Burnham et al., 1991) or in optical 
nerve neuritis (Grauer et al., 2001).  
 
In an attempt to elucidate the molecular targets of GC-induced tightening of the 
barrier, we were able to show that GC signals can directly act at the transcriptional 
level on human occludin and claudin-5 gene expression in a dose-dependent manner. 
This induction of gene expression was further reflected in increased occludin and 
claudin-5 protein synthesis, identifying them as molecular targets of GC action in 
human brain microvascular endothelial cells. Levels of another TJ protein, claudin-1, 
and the adherens junction protein, VE-cadherin remained unchanged by GC 
treatment.  
These data are partly consistent and partly disparate from observations in animal 
models of the BBB, pointing to inter-species differences in GC responsivity: in the 
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mouse BBB model cEND, occludin could similarly be identified as a GR target 
(Förster et al., 2005), while an effect on claudin-5 gene expression by GCs was not 
observed (Förster et al., 2007). Induction of claudin-5 protein by GCs has however 
previously been described in other species than mouse: in rat brain microvessel 
endothelial cells (BMEC, GPNT), addition of HC to the cultures resulted in fewer 
frayed junctions and a more uniform distribution of the TJ protein claudin-5 at the cell 
borders as compared with cultures without GC treatment (Romero et al., 2003; 
Calabria et al., 2006). A recent screen of gene expression by human alveolar 
epithelial cells indicated that claudin-5 is one of the major genes upregulated during 
differentiation in culture (Gonzales et al., 2002; Daugherty et al., 2004). On the other 
hand, responsivity of the human VE-cadherin gene to GCs could not be observed in 
hCMEC/D3 cells, while it represents a GC target in the mouse (Blecharz et al., 2007). 
Reports on GC effects on VE-cadherin in other species or tissues could not be found, 
while the epithelial adherens protein, E-cadherin was reported to be strongly induced 
by GC in human lung epithelial cell lines promoting the formation of an alveolo-
capillary barrier in vitro (Hermanns et al., 2004). In contrast to this, GCs did not 
modulate the production or location of the epithelial cell adhesion protein E-cadherin 
in mouse mammary epithelial cells in vitro (Zettl et al., 1992). Whether this 
differential responsivity of the human, rat and mouse claudin-5 and VE-cadherin 
genes to GCs is based on different temporal gene expression patterns, the diverse GCs 
used or on different inter-species responsivity of the respective gene promoters to 
GCs remains to be investigated in the future. The discrepancy observed is however a 
strong indication to treat the transferability of results obtained in animal models to the 
human system with caution. 
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The contribution of individual TJ proteins on the development or progression of 
neurological conditions is varied. In some cases, TJ alterations and subsequent 
increased BBB permeability are an effect of the underlying pathology; alternatively, 
these changes can be causative and mediating event in disease development. For 
example, TJ disruptions and subsequent BBB perturbations are involved in the 
development of MS (Neuwelt, 2004; Brooks et al., 2006), while ischemic stroke and 
traumatic brain injury lead to BBB perturbations (Ilzecka, 1996). There are many 
diseases, such as Alzheimer's disease, where the direct correlation is not yet known, 
but is currently being investigated (Wardlaw et al., 2003). We thus attempted further 
to validate the hCMEC/D3 cell culture model suitable to study the barrier-preserving 
effects of HC under inflammatory conditions, and were able to demonstrate that 
TNFα treatment leads to divergent down-regulation of the different TJ proteins.  
However, our study demonstrates that the simultaneous administration of HC with 
TNFα preserves the functional integrity of the TJs under inflammatory conditions 
(TNFα exposure). The selective down-regulation of the TJ proteins occludin and 
claudin-5 detected is congruent with other research and clinical reports concerning 
endothelial cells of the BBB (Brooks et al., 2005; Förster et al., 2005; Brooks et al., 
2006; Silwedel & Förster, 2006; Schreibelt et al., 2007) and non-neural endothelium 
(Zeissig et al., 2007). Pre-treatment with HC maintained the TJ component occludin 
while it did not prevent the loss of claudin-5 and VE-cadherin as effectively. The 
observed effects suggest a vulnerability especially of claudin-5 protein to the pro-
inflammatory cytokine. While the TJ transmembrane protein occludin seems to play a 
regulatory role in the control of vascular permeability, since tissue expression and 
content of occludin correlate well with barrier properties (Hirase et al., 1997), the role 
of the different claudins appears to be strand and pore formation (Matter & Balda, 
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2003). Remarkably, differential effects of simultaneaous HC/TNFα-administration on 
gene expression and protein levels of claudin-5 were observed: while no restoration of 
the claudin-5 protein levels could be observed, simultaneous HC/TNFα− treatment 
nevertheless led to increased claudin-5 gene expressin. As an explanation, one might 
refer to previous observations, describing the upregulation of matrix 
metalloproteinases during inflammation in endothelial cells which demonstratably 
leads to the degradation of tight junction transmembrane proteins (MunBryce & 
Rosenberg, 1998) and could chiefly affect the claudin-5 based tight junction structural 
integrity at the protein level. In line with this hypothesis, Nitta et al. reported the 
identification of especially claudin-5 as a critical regulator of brain microvascular 
endothelial cell permeability (Nitta et al., 2003). In retinal microvascular endothelial 
cells, Koto et al. could recently demonstrate that claudin-5 is a target molecule of 
hypoxia leading to the disruption of the barrier function (Koto et al., 2007), while in a 
rat rat cortical cold injury model, Nag et al. were able to demonstrate decreased 
expression of both, occludin and claudin-5 at the site of injury (Nag et al., 2007). 
TNFα and HC thus seem to act in a differential manner on the expression of different 
TJ components in microvascular cells of the BBB. Attention should however also be 
directed to the possibility that exposure to high levels of the proinflammatory 
cytokine TNFα can lead to increased amounts of locally produced VEGF from the 
endothelial cells, which will contribute to the downregulation of TJ proteins and 
increase leakiness of the barrier. HC effects could therefore also be indirect in nature 
by reducing VEGF secretion (Neuwelt, 2004). Future studies will thus have to adress 
the nature of the opposed effects of HC and TNFα or other pro-inflammatory 
cytokines on TJ properties in brain microvascular endothelial cells, i.e. effects on TJ 
transcription, protein synthesis, intracellular localisation, phosphorylation status, on 
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the dynamics of junctional protein interactions, and on the secretion of signalling 
proteins and peptidases, in line with investigations in other cellular systems (Poritz et 
al., 2004; Bruewer et al., 2005; Prasad et al., 2005; Abbott et al., 2006; Förster et al., 
2007).  
Taken together, our observations support the hypothesis that the secretion of pro-
inflammatory cytokines during inflammation in endothelial cells leads to the 
degradation of chiefly claudin-5 and, to a minor extent, occludin, at the human BBB 
and could affect TJ structural integrity, while HC treatment is an effective way to 
prevent this. To the best of our knowledge, this is the first report describing a possible 
role of GCs like HC in direct regulation of the expression of TJ components in human 
brain microvascular endothelial cells. These observations might be of clinical and 
pharmacological significance, since it could open up new specific routes of treatment 
of CNS  inflammatory diseases: at present, high dose GC therapy is used successfully 
in MS relapses. The prevailing opinion on the mode of GC action is that it induces the 
inhibition of cytokine-induced barrier reduction and expression of CAMs (VCAM-1, 
ICAM-1, E-selectin and PECAM-1) which mediate T cell/ BBB interaction and 
consequently chronic leukocyte recruitment across the BBB. In contrast, our 
observations open up a new lead for an understanding of the beneficial effects of GC 
action in a therapeutic regime: An  additional mode of GC action on brain 
microvascular endothelium appears to consist of tightening of the barrier which is 
likely to diminish  leukocyte recruitment across the BBB. After a future identification 
of the recruited transcriptional co-regulator proteins for GR (Beato & Klug, 2000), the 
design of cell- or tissue-specific steroidal drugs might be attempted to treat MS 
patients without the severe side effects of classical GC therapy.” 
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Figure legends. 
Fig. 1.  
(A) After reaching confluence, hCMEC/D3 cells were treated with 50 nM and 100 
nM hydrocortisone (HC) for 48 hours and GR mRNA expression was assessed. 
Treatment was repeated every 24 h. A downregulation of GR transcript to 0.81 + 0.06-
fold after after 48 hours of treatment with 50 nM HC, and to 0.63 + 0.1-fold after 48 
hours of treatment with 100 nM HC, respectively, was observed in hCMEC/D3 cells. 
(B) Confluent monolayers of hCMEC/D3 cells were grown in collagen-IV coated cell 
culture flasks in the presence of 100 nM HC as indicated. Cell lysates were analysed 
by western blot for GR protein contents. After 48 h of HC treatment of hCMEC/D3, a 
downregulation of GR protein to an estimated protein content of 83 + 0.6 % of that in  
untreated cells occurred, (n = 3).  
(C) Immunocytochemistry visualising the cellular localisation of GR protein in 
hCMEC/D3 endothelial cells maintained in serum-reduced medium (0.25 % FCS) 
“control” as compared to cells maintained in differentiation medium (0.25 % FCS, 
110 nM HC) “HC”. GR stain (FITC = green), propidium iodide nuclear counterstain 
(red), and merged images (GR/PI) of GR immunofluorescence (green) and nuclei 
counterstained by propium iodide (red). After 48 h of HC  treatment a nuclear 
concentration of GR (green) in hCMEC/D3 cells  was observed, visualised by 
propidium iodide nuclear counterstaining (red). The nuclear concentration of GR 
could be confirmed for HC treated hCMEC/D3 cells by the use of computer imaging 
software to merge the individual images for FITC-GR and propidium iodide 
counterstain to assess similarity of staining pattern. 
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The slides were analysed using a Zeiss Axioscop2 microscope. All pictures within each 
experiment were captured and manipulated identically with SpotAdvanced software and 
Adobe Photoshop. Bar in the lower panels indicates 20 µm for all panels. 
 
Fig. 2.  
HC induces barrier properties in hCMEC/D3 cells.  
Influence of the addition of HC on the electrical barrier properties (TER) of hCMEC/D3 
monolayers. Growth medium (2.5 % FCS) was changed after 5 days in culture to 
differentiation medium (0.25 % FCS, + additions) and analysis of the TER was 
performed after additional 48 h in vitro, while treatment was repeated every 24 h. 
Incubation medium: (control) with 0.25 % (v/v) FCS, without hydrocortisone; (HC) 
with 0.25 % (v/v) FCS, 100 nM HC; Data are given as mean + sd (n = 6). 
 
Fig. 3. HC effects on junctional protein levels. 
The influence of HC treatment on the junctional proteins occludin, claudin-1, claudin-
5 and VE-cadherin was assessed by Western Blot and densitometric analysis: for this, 
cells were seeded on plastic cell culture flasks coated with collagen IV, treated for 48 
h as as described above and indicated and subjected to SDS-gel electrophoresis and 
Western blotting. An increase in protein levels could be verified for occludin and 
claudin-5. Claudin-5 contents were increased by 62 + 22 % as compared to the 
untreated control, as assessed by western blot analysis and and densitometric 
quantitation. Occludin contents were increased by 16 + 7 % as compared to the 
untreated control. No treatment-related changeswere detected in the cases of claudin-1 
and VE-cadherin (Fig. 3). 
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Fig. 4: HC preservation of hCMEC/D3 barrier function under pro-inflammatory 
conditions 
(A) GC treatment prevents a compromise of BBB function in response to TNFα 
administration for 8 hours: TER drops from 74 + 12 Ω*cm2  in control cells to 42 + 7 
Ω*cm2 in TNFα−treated cells, while treatment with HC increased TER values to 324 
+ 33 Ω*cm2. Simultaneous administration of TNFα with HC effectively prevented 
barrier breakdown, TER values amounted to 157 + 27 Ω*cm2. 
(B) hCMEC/D3 cells were grown in collagen IV-coated cell culture flasks to 
confluence for 5 d and therafter maintained in differentiation medium containing 
various additions for an additional 8 h: 0.25 % FCS; 0.25 % FCS + 100 nM HC; 0.25 
% FCS + 10 nM TNFα; 0.25 % FCS + 100 nM HC + 10 nM TNFα. After 8 h, cell 
lysates were prepared. Cell lysates were analysed by western blot for occludin, 
claudin-5, and VE-cadherin. 8 h of TNFα-treatment decreased occludin protein to 75 
+ 1 % of untreated cells. Pretreatment with HC before TNFα administration increased 
occludin to  110 + 1.5 % of untreated cells and prevented occludin loss. When treated 
with HC alone, occludin was significantly increased to 139 + 4 % of control values. In 
contrast, 8 h of TNFα-treatment decreased claudin-5 protein to 57 + 1 % of untreated 
cells. Simultaneous administration of TNFα and HC yielded reduced levels of 
claudin-5 to 79 + 2 % of untreated cells. When treated with HC alone, claudin-5 
increased to 110 + 1.5 % of control (Fig. 4B). Levels of the adherens junction protein 
VE-cadherin did not show significant changes under most treatment regimes. 
However, HC treatment concomitant with TNFa-treatment led to an increase in 
detectable VE-cadherin protein (118 + 5 % of control) 8 h after treatment. 
(C) Densitometric evaluation of (B) 
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Table 1 
Permeability coefficients (Pe) for fluorescein and FITC-dextrans (4,10, 70 and 
150) of control and HC-treated hCMEC/D3 cells (n = 6-8 filters, 3 independent 
assays). 
 
 
Ap/dx 
(1/cm) 
Solute MW Pe 
(10-3 cm/min) 
control 
Pe 
(10-3 cm/min) 
HC 
Radius 
(Å) 
D 
(10-5 
cm2/min)   control HC 
Fluorescei
n 
389 5.53 + 0.07 3.43 + 0.02 5.5 35.8 15.45 9.58 
FD4 4000 0.83 + 0.03 0.53 + 0.02 14 14 5.93 3.79 
FD10 10000 0.32 + 0.02 0.28 + 0.022 22 8.9 3.6 3.15 
FD70 70000 0.017 + 0.004 0.014 + 0.004 60 3.3 0.52 0.42 
FD150 150000 0.018 + 0.006 0.014 + 
0.0035 
80 2.5 0.72 0.56 
FD, number = FITC dextran, molecular weight in kDa 
D = Diffusion coefficient of the solute 
A = Area 
Pe = Permeability coefficient 
 
 
 
 
 
 
Table 2 
 
Modulation of TJ gene expression in hCMEC/D3 cells by the GC HC.  
 
 
Gene/  statistical significance n = 5 
[nM HC] occludin  claudin-5  claudin-1 
 
 claudin-3 
 
 VE-
cadherin 
 
 
 
10 1.585+0.01 * 1.11+0.21 ns 0.89+0.14 ns 0.89+0.04 ns 0.87+0.03 ns 
50 2.07+0.07 ** 0.84+0.13 ns 0.81+0.04 ns 0.81+0.14 ns 0.98+0.14 ns 
100 2.75+0.04 * 2.32+0.11 ** 0.9+0.06 ns 0.9+0.27 ns 1.06+0.17 ns 
500 1.79+0.54 ** 1.88+0.06 * 0.77+0.01 * 0.77+0.31 ns 0.93+0.1 ns 
1000 1.35+0.28 * 0.43+0.23 ns 0.64+0.07 * 0.635+0.2 * 0.75+0.2 ns 
 
Fold expression versus untreated cells (means + s.d.), followed by statistical 
significance. *P<0.05, **P<0.001. ns, not significant. Values for untreated cells are 
set = 1. HC, hydrocortisone. 
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Table 3 
 
 
Modulation of TJ gene expression in hCMEC/D3 cells by the inflammatory mediator 
TNFα and HC. Values for untreated cells are set = 1. n = 5. 
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